Summary - A new market study, titled “Global Q Fever Market Research Report Forecast to 2023” has been featured on WiseGuyReports.

 

Q fever is a mild disease with flu-like symptoms. In Q fever, the infection is caused by the bacterium Coxiella burnetii. Many patients have no symptoms at all, while, in some cases, the infection could reoccur/resurface years later. Chronic Q fever may damage the heart, liver, brain, lungs, and could cause diabetes in some cases.

The major factors driving the growth of the market include rising prevalence of Q fever coupled with increasing Q fever hospitalization rates, rising worldwide cattle, sheep, and goat population, growth in risk factors of Q fever, and globally growing geriatric population.

The global Q fever market has been segmented on the basis of type, diagnosis, treatment, end user, and region.

 

ALSO READ: https://www.marketwatch.com/press-release/q-fever-industry---treatment-outlook-analysis-research-review-to-2023-2020-09-24

 

The global Q fever market, by type, has been segmented into acute and chronic.

The global Q fever market, by diagnosis, has been segmented into serology tests and others.

The global Q fever market, by treatment, has been segmented into antibiotics and surgery.

The global Q fever market, by end user, has been segmented into patients, hospitals and clinics, and others.

The global Q fever market is expected to reach a market value of USD 9,850.65 million by 2023 from USD 6,249.68 million in 2017 and is expected to register a CAGR of 7.83% during the forecast period of 2018 to 2023. In 2017, Asia-Pacific held the highest share of the market at 44.9%, followed by the Middle East and Africa with a share of 25.4%.

 

Key Players

Merck KGaA, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Basilea Pharmaceutica Ltd, Sanofi S. A., Melinta Therapeutics, Inc., Bayer AG, Johnson & Johnson Services, Inc., Yashica Pharmaceuticals, and AtoxBio.

Study Objectives

  • To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the Q fever market
  • To provide insights into factors affecting the market growth
  • To analyze the global Q fever market based on various tools such as supply chain analysis and Porter’s five force analysis
  • To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
  • To provide country-level analysis of the market with respect to the current market size and future perspective
  • To provide country-level analysis of the market for segments by type, diagnosis, treatment, end user, and region
  • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies and drawing a competitive landscape for the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Q fever market

Target Audience

  • Hospitals
  • Q fever Companies
  • Associations and Organizations

Key Findings

  • The global Q fever market is expected to reach USD 9,850.65 million by 2023 at a CAGR of 7.83% from 2018 to 2023
  • On the basis of type, the chronic segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 7.33% during the forecast period
  • On the basis of diagnosis, the serology tests segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 8.32% during the forecast period
  • On the basis of treatment, the antibiotics segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 7.32% during the forecast period
  • On the basis of end user, the patients segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 8.21% during the forecast period

Regional Analysis

  • Americas

o North America

 US

 Canada

o Latin America

  • Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

  • Asia-Pacific

o Japan

o China

o India

o Australia

o Republic of Korea

o Rest of Asia-Pacific

  • Middle East & Africa

o UAE

o Saudi Arabia

o Oman

o Kuwait

o Qatar

o Africa

o Rest of the Middle East & Africa

 

FOR MORE DETAILS: https://www.wiseguyreports.com/reports/4255640-global-q-fever-market-research-report-forecast-to-2023

 

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.               

 

Contact Us:

NORAH TRENT                                                      

[email protected]       

Ph: +162-825-80070 (US)                          

Ph: +44 203 500 2763 (UK)